Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
IMNM Insider Trading: Immunome Inc. Insider Buys and Sells · https://wallstpal.com/stock/imnm/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

Immunome Inc. (IMNM) Insider Trading

15 open-market trades reported since Jun 17, 2026: 0 purchases worth $0 and 15 sales worth $16.0M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Jack HigginsChief Scientific Officer0$01$334KSep 15, 2026
Isaac BarchasDirector0$09$9.94MAug 12, 2026
Kinney HornCHIEF BUSINESS OFFICER0$02$2.30MAug 6, 2026
Robert LechleiderChief Medical Officer0$02$2.34MJul 7, 2026
Max RosettCFO0$01$1.09MJun 17, 2026

All trades

IMNM insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 15Sep 11Jack HigginsChief Scientific OfficerChief Scientific Officer▼ SELL10b5-113,20025.32$334K−17%Form 4 ↗
Aug 12Aug 11Isaac BarchasDirectorDirector (ind.)▼ SELL10b5-162,29126.23$1.63MAll soldForm 4 ↗
Aug 12Aug 12Isaac BarchasDirectorDirector▼ SELL10b5-111,04827.25$301K−11%Form 4 ↗
Aug 12Aug 10Isaac BarchasDirectorDirector (ind.)▼ SELL10b5-110,12526.07$264K−14%Form 4 ↗
Aug 10Aug 6Isaac BarchasDirectorDirector (ind.)▼ SELL10b5-120,84026.06$543K−19%Form 4 ↗
Aug 10Aug 7Isaac BarchasDirectorDirector (ind.)▼ SELL10b5-115,24826.06$397K−17%Form 4 ↗
Aug 6Aug 4Kinney HornCHIEF BUSINESS OFFICERCHIEF BUSINESS OFFICER▼ SELL10b5-190,61625.09$2.27MAll soldForm 4 ↗
Jul 9Jul 7Kinney HornCHIEF BUSINESS OFFICERCHIEF BUSINESS OFFICER▼ SELL10b5-11,09225.00$27KAll soldForm 4 ↗
Jul 7Jul 6Isaac BarchasDirectorDirector (ind.)▼ SELL10b5-183,09424.11$2.00M−40%Form 4 ↗
Jul 7Jul 2Robert LechleiderChief Medical OfficerChief Medical Officer▼ SELL10b5-155,00022.62$1.24M−78%Form 4 ↗
Jul 7Jul 7Isaac BarchasDirectorDirector (ind.)▼ SELL10b5-116,90624.20$409K−14%Form 4 ↗
Jul 2Jul 2Isaac BarchasDirectorDirector (ind.)▼ SELL10b5-1100,00022.59$2.26M−32%Form 4 ↗
Jul 2Jun 30Isaac BarchasDirectorDirector (ind.)▼ SELL10b5-1101,05021.12$2.13M−25%Form 4 ↗
Jun 29Jun 25Robert LechleiderChief Medical OfficerChief Medical Officer▼ SELL10b5-155,00019.85$1.09M−78%Form 4 ↗
Jun 17Jun 15Max RosettCFOCFO▼ SELL10b5-160,00018.23$1.09M−53%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings